1. Home
  2. TENX vs INHD Comparison

TENX vs INHD Comparison

Compare TENX & INHD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TENX
  • INHD
  • Stock Information
  • Founded
  • TENX 1967
  • INHD 2019
  • Country
  • TENX United States
  • INHD United States
  • Employees
  • TENX N/A
  • INHD N/A
  • Industry
  • TENX Biotechnology: Pharmaceutical Preparations
  • INHD
  • Sector
  • TENX Health Care
  • INHD
  • Exchange
  • TENX Nasdaq
  • INHD Nasdaq
  • Market Cap
  • TENX 21.7M
  • INHD 19.8M
  • IPO Year
  • TENX N/A
  • INHD 2023
  • Fundamental
  • Price
  • TENX $6.30
  • INHD $4.86
  • Analyst Decision
  • TENX Strong Buy
  • INHD
  • Analyst Count
  • TENX 3
  • INHD 0
  • Target Price
  • TENX $16.00
  • INHD N/A
  • AVG Volume (30 Days)
  • TENX 20.7K
  • INHD 7.2K
  • Earning Date
  • TENX 05-13-2025
  • INHD 05-12-2025
  • Dividend Yield
  • TENX N/A
  • INHD N/A
  • EPS Growth
  • TENX N/A
  • INHD N/A
  • EPS
  • TENX N/A
  • INHD N/A
  • Revenue
  • TENX N/A
  • INHD $916,878.00
  • Revenue This Year
  • TENX N/A
  • INHD N/A
  • Revenue Next Year
  • TENX N/A
  • INHD N/A
  • P/E Ratio
  • TENX N/A
  • INHD N/A
  • Revenue Growth
  • TENX N/A
  • INHD 39.48
  • 52 Week Low
  • TENX $2.77
  • INHD $3.00
  • 52 Week High
  • TENX $7.89
  • INHD $9.10
  • Technical
  • Relative Strength Index (RSI)
  • TENX 49.26
  • INHD 59.09
  • Support Level
  • TENX $6.00
  • INHD $4.30
  • Resistance Level
  • TENX $6.76
  • INHD $4.81
  • Average True Range (ATR)
  • TENX 0.40
  • INHD 0.23
  • MACD
  • TENX 0.02
  • INHD 0.05
  • Stochastic Oscillator
  • TENX 39.47
  • INHD 83.42

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.

About INHD Inno Holdings Inc.

Inno Holdings Inc is a building technology company with a mission to transform the construction industry with its proprietary cold-formed steel-framing technology and other innovations. It is a manufacturer of cold-formed-steel members and prefabricated homes. It offers a full range of services required to transform raw materials into precise steel framing products and prefabricated homes. The company sells these finished products either to businesses or directly to customers. The finished products and cold-formed-steel members are used in a variety of building types, including residential, commercial, industrial and infrastructure.

Share on Social Networks: